Oligonucleotide APIs Market Poised for Robust Growth USD 4.84 Billion with a Projected CAGR of 5.60%

The global oligonucleotide active pharmaceutical ingredients (APIs) market is set for significant expansion over the next decade, driven by the increasing demand for new drug classes. According to recent projections, the market is anticipated to grow at a robust compound annual growth rate (CAGR) of 5.60% from 2024 to 2034. Starting from a valuation of …

Oligonucleotide API Market is anticipated to grow at a strong 5.60% CAGR to reach USD 4.84 Billion By 2034 | FMI Analysis

The quest for groundbreaking treatments is driving rapid growth in the Oligonucleotide API Market. These specialized molecules are essential building blocks for developing new drug classes to combat a wide range of diseases. According to a recent analysis, the market is poised for significant expansion, with a projected Compound Annual Growth Rate (CAGR) of 5.60% …